International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8053840
Original Article
Clinical Profile of Ocular Injuries in Pediatric Age Group Attending Department of Ophthalmology- VIMS, Ballari- A Prospective Study
 ,
 ,
 ,
Published
June 19, 2023
Abstract
Background: Ocular trauma is a significant contributor to preventable monocular blindness and visual impairment globally, necessitating a comprehensive understanding of its epidemiology and risk factors. This study aimed to analyze pediatric ocular trauma's prevalence, patterns, and related factors at Vijayanagar Institute of Medical Sciences, Ballari, India. Methods: A prospective study was conducted over 1.5 years, involving 60 pediatric ocular trauma cases. Results: The highest incidence was found in children aged 6-9 years (41.67%), followed by 9-12 years (25%). Males were more affected (66.7%) than females. Most cases (56.67%) were from rural areas. About 50% of the patients presented to the hospital between 24 hours and 3 days post-injury. Home was the most common location of injury (46.67%), followed by playgrounds (23.33%). Open globe injuries were the most common (58.34%), with vegetative matter being the primary cause (36.67%). The most common area of open globe injury was Zone 1 (88.57%). Conclusions: Our study highlights the significance of ocular trauma in children, emphasizing the need for targeted interventions and awareness programs to prevent these incidents.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1706 Views
454 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved